Recently, agent based technologies have been considered in order to increase both knowledge level and intelligence of real and virtual objects.
Fundus photography-based retinal oximetry has the potential to quantify sO2 [ 6, 7] and several optical coherence tomography (OCT) based technologies have been reported to measure retinal blood flow [ 8– 12]; but each individual technology is insufficient to measure MRO2 as both sO2 and blood flow measurements are required.
To maximize distillate production from subsequent hydrocracking of the F T wax, a low temperature, cobalt catalyst based technology has been selected.
Although plasmid based technology has been used for the expression of mammalian proteomes, it requires a large investment as well as laboratory automation [9].
Recently, peptide array based technology has been developed and is becoming increasingly available [ 33, 34].
In addition, polymerase chain reaction (PCR) based technology has been demonstrated to successfully evaluate specific mRNAs, especially those present in low copy numbers in a small number of cells or in small quantities of tissue, and mRNAs expressed in mixed-cell populations.
The process simulation model developed for designing and optimizing MED-based technologies has been experimentally demonstrated to be consistent with the pilot plant performance.
This is motivated by the fact that the energy efficiency problem in OFDMA-based technologies has been mainly analyzed for the data transmission phase (see [8] and [9] and references therein).
A palette of mass spectrometry-based technologies has been applied for lipidome profiling.
An uninterruptible power supply (UPS) based on hydrogen technologies has been designed, manufactured and tested.
RNAseq, based on recent next generation sequencing technologies, has been a widely used to obtain transcriptomic information on genes that are differentially expressed under contrasting biological conditions, including testis vs. ovary or different reproductive stages [ 64, 65].
